| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Transplantation, Heterologous | 96 | 2024 | 2391 | 11.200 |
Why?
|
| Graft Rejection | 70 | 2024 | 4504 | 5.560 |
Why?
|
| Lung Transplantation | 45 | 2024 | 1310 | 5.350 |
Why?
|
| Body Composition | 136 | 2018 | 2441 | 5.230 |
Why?
|
| Graft Survival | 67 | 2024 | 3904 | 4.930 |
Why?
|
| Heart Transplantation | 61 | 2024 | 3306 | 4.210 |
Why?
|
| Swine | 76 | 2024 | 5987 | 3.460 |
Why?
|
| Galactosyltransferases | 16 | 2022 | 283 | 3.090 |
Why?
|
| Animals, Genetically Modified | 35 | 2024 | 1562 | 2.910 |
Why?
|
| CD40 Ligand | 17 | 2024 | 528 | 2.860 |
Why?
|
| Absorptiometry, Photon | 74 | 2018 | 1707 | 2.280 |
Why?
|
| Papio | 19 | 2024 | 672 | 2.010 |
Why?
|
| Adipose Tissue | 80 | 2018 | 3314 | 1.800 |
Why?
|
| Histamine | 6 | 2022 | 496 | 1.500 |
Why?
|
| Complement System Proteins | 14 | 2023 | 738 | 1.460 |
Why?
|
| Neutron Activation Analysis | 23 | 2003 | 35 | 1.410 |
Why?
|
| Organ Transplantation | 10 | 2022 | 1172 | 1.410 |
Why?
|
| Antibodies | 16 | 2023 | 2421 | 1.390 |
Why?
|
| Tissue Donors | 16 | 2024 | 2392 | 1.380 |
Why?
|
| Immunosuppressive Agents | 24 | 2024 | 4215 | 1.290 |
Why?
|
| Thrombocytopenia | 8 | 2022 | 1172 | 1.240 |
Why?
|
| Macaca fascicularis | 21 | 2019 | 908 | 1.240 |
Why?
|
| Body Water | 45 | 2008 | 337 | 1.160 |
Why?
|
| Lung Injury | 4 | 2017 | 432 | 1.140 |
Why?
|
| Potassium | 45 | 2008 | 1314 | 1.110 |
Why?
|
| Lung | 20 | 2023 | 10067 | 1.070 |
Why?
|
| Perfusion | 21 | 2023 | 1409 | 1.070 |
Why?
|
| Animals | 138 | 2024 | 168930 | 1.060 |
Why?
|
| Heart | 16 | 2022 | 4425 | 1.030 |
Why?
|
| Anthropometry | 29 | 2009 | 1336 | 0.980 |
Why?
|
| Antigens, Heterophile | 3 | 2022 | 71 | 0.920 |
Why?
|
| Tissue and Organ Procurement | 9 | 2024 | 987 | 0.910 |
Why?
|
| Bone Density | 37 | 2010 | 3491 | 0.880 |
Why?
|
| Antibodies, Monoclonal | 14 | 2023 | 9244 | 0.860 |
Why?
|
| Vascular Resistance | 15 | 2018 | 939 | 0.810 |
Why?
|
| Complement Activation | 12 | 2017 | 447 | 0.800 |
Why?
|
| Models, Animal | 5 | 2021 | 2121 | 0.780 |
Why?
|
| Lymphocyte Depletion | 3 | 2017 | 606 | 0.770 |
Why?
|
| Heart-Assist Devices | 12 | 2011 | 1287 | 0.770 |
Why?
|
| Endothelial Cells | 5 | 2018 | 3581 | 0.760 |
Why?
|
| Brain Death | 3 | 2024 | 360 | 0.760 |
Why?
|
| Galactose | 1 | 2023 | 299 | 0.760 |
Why?
|
| Primates | 9 | 2023 | 519 | 0.750 |
Why?
|
| Leukocytes | 4 | 2018 | 2035 | 0.710 |
Why?
|
| von Willebrand Factor | 3 | 2021 | 680 | 0.700 |
Why?
|
| Isoantigens | 2 | 2022 | 562 | 0.690 |
Why?
|
| Body Mass Index | 43 | 2018 | 13050 | 0.690 |
Why?
|
| Body Weight | 51 | 2010 | 4626 | 0.670 |
Why?
|
| Humans | 379 | 2024 | 766766 | 0.660 |
Why?
|
| Clinical Trials as Topic | 11 | 2024 | 8045 | 0.660 |
Why?
|
| Blood | 10 | 2014 | 597 | 0.650 |
Why?
|
| Skinfold Thickness | 18 | 2011 | 164 | 0.640 |
Why?
|
| Complement Inactivator Proteins | 4 | 2007 | 74 | 0.620 |
Why?
|
| Isoantibodies | 8 | 2023 | 681 | 0.620 |
Why?
|
| Electric Impedance | 14 | 2005 | 791 | 0.620 |
Why?
|
| Cytomegalovirus Infections | 4 | 2022 | 838 | 0.610 |
Why?
|
| Islets of Langerhans Transplantation | 7 | 2017 | 747 | 0.610 |
Why?
|
| Gene Knockout Techniques | 7 | 2017 | 803 | 0.590 |
Why?
|
| Puberty | 10 | 2006 | 495 | 0.570 |
Why?
|
| Sus scrofa | 3 | 2015 | 431 | 0.560 |
Why?
|
| Transplantation, Heterotopic | 5 | 2012 | 175 | 0.530 |
Why?
|
| Body Constitution | 8 | 2003 | 273 | 0.530 |
Why?
|
| Antigens, CD20 | 2 | 2010 | 199 | 0.530 |
Why?
|
| Patient Selection | 9 | 2024 | 4252 | 0.520 |
Why?
|
| HLA Antigens | 3 | 2022 | 1339 | 0.520 |
Why?
|
| Kidney | 7 | 2024 | 7074 | 0.520 |
Why?
|
| Transplantation, Homologous | 18 | 2023 | 4860 | 0.520 |
Why?
|
| E-Selectin | 1 | 2018 | 575 | 0.500 |
Why?
|
| Reperfusion Injury | 3 | 2021 | 1043 | 0.500 |
Why?
|
| B-Lymphocytes | 6 | 2017 | 4784 | 0.500 |
Why?
|
| Heart-Lung Transplantation | 5 | 2004 | 87 | 0.500 |
Why?
|
| P-Selectin | 1 | 2018 | 598 | 0.490 |
Why?
|
| Cyclosporine | 6 | 2010 | 778 | 0.490 |
Why?
|
| Chagas Disease | 1 | 2016 | 166 | 0.470 |
Why?
|
| Trypanosoma cruzi | 1 | 2016 | 204 | 0.470 |
Why?
|
| Platelet Glycoprotein GPIb-IX Complex | 4 | 2021 | 144 | 0.460 |
Why?
|
| Antibodies, Heterophile | 5 | 2009 | 128 | 0.460 |
Why?
|
| Coronary Artery Bypass, Off-Pump | 7 | 2008 | 65 | 0.450 |
Why?
|
| Models, Biological | 37 | 2011 | 9461 | 0.450 |
Why?
|
| Kidney Transplantation | 10 | 2024 | 4278 | 0.450 |
Why?
|
| Thromboxanes | 4 | 2005 | 45 | 0.440 |
Why?
|
| Heart Diseases | 7 | 2020 | 2817 | 0.440 |
Why?
|
| Sex Characteristics | 20 | 2008 | 2645 | 0.430 |
Why?
|
| Antibody Formation | 6 | 2011 | 1392 | 0.420 |
Why?
|
| Respiratory Insufficiency | 2 | 2017 | 1241 | 0.410 |
Why?
|
| Neutrons | 3 | 2010 | 78 | 0.410 |
Why?
|
| Adiposity | 7 | 2012 | 1892 | 0.400 |
Why?
|
| Carbon | 4 | 2010 | 673 | 0.390 |
Why?
|
| Pulmonary Circulation | 11 | 2007 | 744 | 0.390 |
Why?
|
| N-Acetylneuraminic Acid | 2 | 2022 | 174 | 0.390 |
Why?
|
| Myocardium | 12 | 2010 | 4765 | 0.390 |
Why?
|
| Extracellular Space | 18 | 2008 | 563 | 0.380 |
Why?
|
| Acquired Immunodeficiency Syndrome | 13 | 2003 | 2205 | 0.380 |
Why?
|
| Arteriosclerosis | 2 | 2015 | 1055 | 0.380 |
Why?
|
| Nutrition Disorders | 7 | 1991 | 203 | 0.370 |
Why?
|
| Antigens | 3 | 2022 | 1441 | 0.360 |
Why?
|
| Male | 206 | 2024 | 364142 | 0.350 |
Why?
|
| Organ Preservation | 6 | 2019 | 400 | 0.350 |
Why?
|
| Reoperation | 6 | 2017 | 4325 | 0.350 |
Why?
|
| Anemia | 3 | 2016 | 1514 | 0.340 |
Why?
|
| Vascular Diseases | 2 | 2018 | 1161 | 0.340 |
Why?
|
| Blood Platelets | 7 | 2021 | 2465 | 0.340 |
Why?
|
| Reference Values | 24 | 2007 | 4913 | 0.330 |
Why?
|
| Female | 205 | 2024 | 396520 | 0.330 |
Why?
|
| Calcium | 12 | 1999 | 5783 | 0.320 |
Why?
|
| T-Lymphocytes | 13 | 2017 | 10264 | 0.320 |
Why?
|
| Energy Metabolism | 10 | 2010 | 2903 | 0.320 |
Why?
|
| Muscle, Skeletal | 11 | 2009 | 4970 | 0.310 |
Why?
|
| Amenorrhea | 4 | 2007 | 470 | 0.310 |
Why?
|
| Adult | 156 | 2024 | 223307 | 0.300 |
Why?
|
| Regression Analysis | 29 | 2008 | 6329 | 0.300 |
Why?
|
| Epitopes | 2 | 2014 | 2526 | 0.300 |
Why?
|
| Immunomodulation | 1 | 2012 | 548 | 0.300 |
Why?
|
| Influenza A Virus, H2N2 Subtype | 1 | 2007 | 3 | 0.300 |
Why?
|
| Guanidines | 2 | 1999 | 194 | 0.300 |
Why?
|
| Sesquiterpenes | 2 | 1999 | 175 | 0.290 |
Why?
|
| Age Factors | 22 | 2024 | 18397 | 0.290 |
Why?
|
| Health Physics | 1 | 2007 | 35 | 0.290 |
Why?
|
| beta-Thromboglobulin | 1 | 2007 | 20 | 0.290 |
Why?
|
| Hemodynamics | 9 | 2022 | 4188 | 0.280 |
Why?
|
| Middle Aged | 150 | 2024 | 223257 | 0.280 |
Why?
|
| Histocompatibility | 3 | 2017 | 327 | 0.280 |
Why?
|
| Body Height | 18 | 2010 | 1562 | 0.280 |
Why?
|
| Immune Tolerance | 6 | 2009 | 2325 | 0.280 |
Why?
|
| Antilymphocyte Serum | 6 | 2017 | 492 | 0.280 |
Why?
|
| Thrombosis | 6 | 2015 | 2953 | 0.270 |
Why?
|
| Blood Coagulation | 6 | 2014 | 1163 | 0.270 |
Why?
|
| Autoantibodies | 1 | 2015 | 2115 | 0.270 |
Why?
|
| Aorta | 1 | 2014 | 2043 | 0.270 |
Why?
|
| Platelet Aggregation | 3 | 2021 | 769 | 0.270 |
Why?
|
| Nutritional Status | 6 | 2010 | 1621 | 0.270 |
Why?
|
| Genetic Engineering | 1 | 2012 | 936 | 0.260 |
Why?
|
| Antigens, CD | 7 | 2017 | 4032 | 0.260 |
Why?
|
| New York City | 8 | 2015 | 736 | 0.260 |
Why?
|
| Time Factors | 35 | 2024 | 40149 | 0.260 |
Why?
|
| Spinal Cord Injuries | 6 | 2006 | 927 | 0.250 |
Why?
|
| Aging | 18 | 2009 | 8731 | 0.250 |
Why?
|
| Biomedical Research | 3 | 2024 | 3459 | 0.250 |
Why?
|
| Vimentin | 1 | 2005 | 257 | 0.240 |
Why?
|
| Postoperative Complications | 17 | 2020 | 15831 | 0.240 |
Why?
|
| Disaccharides | 4 | 2015 | 170 | 0.230 |
Why?
|
| Transplantation Immunology | 4 | 2015 | 540 | 0.230 |
Why?
|
| Obesity | 26 | 2012 | 13090 | 0.230 |
Why?
|
| Complement C1 Inactivator Proteins | 2 | 2003 | 89 | 0.230 |
Why?
|
| Models, Immunological | 2 | 2015 | 517 | 0.230 |
Why?
|
| Tissue Survival | 4 | 2007 | 120 | 0.220 |
Why?
|
| Aged | 99 | 2024 | 171343 | 0.220 |
Why?
|
| Informed Consent | 4 | 2024 | 1010 | 0.220 |
Why?
|
| Food Preferences | 2 | 2018 | 397 | 0.220 |
Why?
|
| Aurintricarboxylic Acid | 1 | 2003 | 10 | 0.220 |
Why?
|
| Complement C3-C5 Convertases | 1 | 2003 | 30 | 0.220 |
Why?
|
| Congresses as Topic | 2 | 2019 | 811 | 0.210 |
Why?
|
| Awards and Prizes | 1 | 2007 | 365 | 0.210 |
Why?
|
| Phantoms, Imaging | 5 | 1999 | 2474 | 0.210 |
Why?
|
| Transplants | 2 | 2021 | 209 | 0.210 |
Why?
|
| Magnesium | 1 | 2006 | 815 | 0.210 |
Why?
|
| Milk Proteins | 2 | 2001 | 161 | 0.210 |
Why?
|
| Monkey Diseases | 2 | 2016 | 71 | 0.200 |
Why?
|
| Radioisotope Dilution Technique | 7 | 2003 | 70 | 0.200 |
Why?
|
| Mycophenolic Acid | 2 | 2016 | 349 | 0.200 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 2003 | 282 | 0.200 |
Why?
|
| Blood Transfusion | 3 | 2016 | 1308 | 0.200 |
Why?
|
| Bioengineering | 1 | 2023 | 97 | 0.200 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 4 | 2006 | 897 | 0.200 |
Why?
|
| Complement C3a | 3 | 2007 | 66 | 0.190 |
Why?
|
| Lymphoid Tissue | 1 | 2003 | 445 | 0.190 |
Why?
|
| Acute Disease | 12 | 2007 | 7241 | 0.190 |
Why?
|
| Selectins | 1 | 2022 | 101 | 0.190 |
Why?
|
| Deamino Arginine Vasopressin | 1 | 2022 | 87 | 0.190 |
Why?
|
| Anticoagulants | 4 | 2015 | 4855 | 0.190 |
Why?
|
| Heart Failure | 13 | 2022 | 11882 | 0.190 |
Why?
|
| Tissue Transplantation | 2 | 2015 | 128 | 0.190 |
Why?
|
| Blood Group Incompatibility | 1 | 2002 | 134 | 0.190 |
Why?
|
| Research | 4 | 2017 | 1977 | 0.190 |
Why?
|
| Weight Loss | 10 | 2006 | 2712 | 0.190 |
Why?
|
| Osteopontin | 1 | 2023 | 305 | 0.190 |
Why?
|
| Creatinine | 3 | 2006 | 1917 | 0.190 |
Why?
|
| Choice Behavior | 2 | 2018 | 846 | 0.190 |
Why?
|
| Minerals | 6 | 2002 | 278 | 0.180 |
Why?
|
| Neuraminic Acids | 2 | 2017 | 16 | 0.180 |
Why?
|
| Graft Enhancement, Immunologic | 1 | 2001 | 58 | 0.180 |
Why?
|
| Thoracotomy | 2 | 2006 | 374 | 0.180 |
Why?
|
| Dipeptides | 1 | 2003 | 386 | 0.180 |
Why?
|
| Coronary Artery Disease | 4 | 2017 | 6558 | 0.180 |
Why?
|
| Dancing | 1 | 2002 | 105 | 0.180 |
Why?
|
| Paraplegia | 4 | 2003 | 161 | 0.180 |
Why?
|
| Waist-Hip Ratio | 4 | 2012 | 521 | 0.180 |
Why?
|
| Weight Gain | 4 | 2015 | 2356 | 0.180 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2003 | 255 | 0.180 |
Why?
|
| Elements | 6 | 2000 | 20 | 0.170 |
Why?
|
| Swine, Miniature | 2 | 2014 | 972 | 0.170 |
Why?
|
| Respiratory Function Tests | 3 | 2020 | 1691 | 0.170 |
Why?
|
| Oxygen | 2 | 2010 | 4251 | 0.170 |
Why?
|
| Fibroblast Growth Factor 1 | 1 | 1999 | 53 | 0.170 |
Why?
|
| Hypertension, Pulmonary | 3 | 2005 | 1604 | 0.170 |
Why?
|
| Aged, 80 and over | 38 | 2012 | 59550 | 0.170 |
Why?
|
| Inflammation | 5 | 2022 | 10860 | 0.170 |
Why?
|
| Immunoglobulin G | 5 | 2023 | 4559 | 0.170 |
Why?
|
| Neutrophils | 3 | 2018 | 3782 | 0.170 |
Why?
|
| Cytotoxicity, Immunologic | 2 | 2017 | 1352 | 0.170 |
Why?
|
| ABO Blood-Group System | 1 | 2002 | 381 | 0.170 |
Why?
|
| Transplantation Tolerance | 3 | 2018 | 641 | 0.170 |
Why?
|
| Membrane Glycoproteins | 3 | 1999 | 3702 | 0.170 |
Why?
|
| Appetite Stimulants | 1 | 1999 | 14 | 0.160 |
Why?
|
| Immunohistochemistry | 8 | 2012 | 11061 | 0.160 |
Why?
|
| Anastomosis, Surgical | 1 | 2003 | 992 | 0.160 |
Why?
|
| Megestrol Acetate | 1 | 1999 | 18 | 0.160 |
Why?
|
| Bronchi | 2 | 2003 | 847 | 0.160 |
Why?
|
| Waiting Lists | 2 | 2004 | 779 | 0.160 |
Why?
|
| Saphenous Vein | 4 | 2006 | 519 | 0.160 |
Why?
|
| Recombinant Proteins | 4 | 2015 | 6507 | 0.160 |
Why?
|
| Bromides | 4 | 2008 | 22 | 0.160 |
Why?
|
| Muscles | 9 | 1995 | 1576 | 0.160 |
Why?
|
| Thorax | 1 | 2022 | 555 | 0.160 |
Why?
|
| Birth Weight | 2 | 2015 | 2123 | 0.160 |
Why?
|
| Treatment Outcome | 27 | 2024 | 65273 | 0.160 |
Why?
|
| Myocardial Revascularization | 2 | 2002 | 795 | 0.160 |
Why?
|
| Maryland | 2 | 2017 | 277 | 0.160 |
Why?
|
| Analysis of Variance | 11 | 2006 | 6214 | 0.160 |
Why?
|
| Cytomegalovirus | 2 | 2022 | 754 | 0.150 |
Why?
|
| Fats | 1 | 1999 | 99 | 0.150 |
Why?
|
| Intracellular Fluid | 8 | 2003 | 201 | 0.150 |
Why?
|
| Leptin | 4 | 2007 | 1596 | 0.150 |
Why?
|
| Anniversaries and Special Events | 1 | 2019 | 97 | 0.150 |
Why?
|
| Radiography, Thoracic | 3 | 2020 | 1320 | 0.150 |
Why?
|
| Gene Expression | 7 | 2019 | 7585 | 0.150 |
Why?
|
| Blood Gas Monitoring, Transcutaneous | 1 | 2018 | 34 | 0.150 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 2 | 2016 | 577 | 0.150 |
Why?
|
| History, 20th Century | 5 | 2017 | 2764 | 0.150 |
Why?
|
| Prothrombin | 3 | 2007 | 194 | 0.150 |
Why?
|
| Heart Ventricles | 6 | 2019 | 3832 | 0.150 |
Why?
|
| Platelet Activation | 5 | 2016 | 643 | 0.150 |
Why?
|
| Myocardial Ischemia | 4 | 2005 | 2132 | 0.150 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2022 | 668 | 0.150 |
Why?
|
| Cause of Death | 7 | 2006 | 3716 | 0.150 |
Why?
|
| Bone and Bones | 9 | 2003 | 2559 | 0.140 |
Why?
|
| Immunoconjugates | 2 | 2007 | 976 | 0.140 |
Why?
|
| Skin Transplantation | 4 | 2001 | 1097 | 0.140 |
Why?
|
| Sialic Acids | 1 | 2017 | 122 | 0.140 |
Why?
|
| Survival Rate | 12 | 2017 | 12825 | 0.140 |
Why?
|
| Glomerular Filtration Rate | 2 | 2024 | 2232 | 0.140 |
Why?
|
| Iron | 1 | 2006 | 1812 | 0.140 |
Why?
|
| Integrins | 1 | 2022 | 839 | 0.140 |
Why?
|
| Heme Oxygenase-1 | 2 | 2022 | 364 | 0.140 |
Why?
|
| Child | 37 | 2024 | 80668 | 0.140 |
Why?
|
| Lipoproteins | 1 | 2022 | 871 | 0.140 |
Why?
|
| HIV Infections | 11 | 2007 | 17536 | 0.140 |
Why?
|
| Adolescent | 49 | 2013 | 88904 | 0.140 |
Why?
|
| Muscle Development | 1 | 1999 | 258 | 0.140 |
Why?
|
| Reactive Oxygen Species | 2 | 2021 | 2142 | 0.140 |
Why?
|
| Influenza, Human | 2 | 2007 | 1543 | 0.140 |
Why?
|
| Aprotinin | 2 | 2008 | 94 | 0.140 |
Why?
|
| Asia | 4 | 2000 | 629 | 0.140 |
Why?
|
| Whole-Body Counting | 7 | 2003 | 36 | 0.130 |
Why?
|
| Catheters | 1 | 2020 | 428 | 0.130 |
Why?
|
| Bone Development | 2 | 2001 | 470 | 0.130 |
Why?
|
| Cytokines | 4 | 2020 | 7438 | 0.130 |
Why?
|
| Organ Specificity | 1 | 2021 | 1966 | 0.130 |
Why?
|
| Adaptive Immunity | 1 | 2021 | 734 | 0.130 |
Why?
|
| Forecasting | 4 | 2022 | 2936 | 0.130 |
Why?
|
| Ventilator Weaning | 1 | 2017 | 170 | 0.130 |
Why?
|
| New York | 7 | 2012 | 879 | 0.130 |
Why?
|
| Body Fluid Compartments | 4 | 2003 | 49 | 0.130 |
Why?
|
| Deep Sedation | 1 | 2017 | 119 | 0.130 |
Why?
|
| Physiology | 1 | 1996 | 112 | 0.130 |
Why?
|
| Bronchogenic Cyst | 1 | 1995 | 28 | 0.130 |
Why?
|
| Densitometry | 3 | 1991 | 150 | 0.130 |
Why?
|
| Transplantation | 1 | 2017 | 222 | 0.130 |
Why?
|
| Reproducibility of Results | 14 | 2012 | 20144 | 0.120 |
Why?
|
| Disease Susceptibility | 2 | 2021 | 1791 | 0.120 |
Why?
|
| Macrophages | 4 | 2023 | 5783 | 0.120 |
Why?
|
| Research Design | 3 | 2024 | 6207 | 0.120 |
Why?
|
| Human Growth Hormone | 1 | 2000 | 640 | 0.120 |
Why?
|
| Narcotics | 1 | 2017 | 332 | 0.120 |
Why?
|
| Thrombin | 4 | 2006 | 600 | 0.120 |
Why?
|
| Cardiac Surgical Procedures | 5 | 2005 | 3684 | 0.120 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 1996 | 319 | 0.120 |
Why?
|
| Quadriplegia | 2 | 2003 | 227 | 0.120 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2002 | 1721 | 0.120 |
Why?
|
| Immunogenetics | 1 | 1994 | 62 | 0.120 |
Why?
|
| Indicator Dilution Techniques | 3 | 2008 | 43 | 0.120 |
Why?
|
| Nitrogen | 5 | 1998 | 344 | 0.120 |
Why?
|
| Coronary Vessels | 4 | 2004 | 3100 | 0.120 |
Why?
|
| Interleukin-8 | 1 | 2018 | 702 | 0.120 |
Why?
|
| Retrospective Studies | 28 | 2024 | 81635 | 0.120 |
Why?
|
| Renal Insufficiency | 2 | 2016 | 811 | 0.120 |
Why?
|
| Capillary Permeability | 3 | 2006 | 772 | 0.120 |
Why?
|
| Hormones | 2 | 2006 | 866 | 0.120 |
Why?
|
| Immunity, Innate | 2 | 2021 | 3077 | 0.110 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2007 | 3446 | 0.110 |
Why?
|
| Gamma Rays | 7 | 2000 | 324 | 0.110 |
Why?
|
| History, 21st Century | 4 | 2019 | 1574 | 0.110 |
Why?
|
| Graft Occlusion, Vascular | 3 | 2006 | 538 | 0.110 |
Why?
|
| Renal Dialysis | 4 | 2002 | 1790 | 0.110 |
Why?
|
| Blood Cell Count | 2 | 2007 | 405 | 0.110 |
Why?
|
| Nutrition Assessment | 3 | 2003 | 739 | 0.110 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 2 | 2010 | 696 | 0.110 |
Why?
|
| Sex Factors | 17 | 2008 | 10619 | 0.110 |
Why?
|
| Endothelium, Vascular | 4 | 2015 | 4424 | 0.110 |
Why?
|
| Sodium Compounds | 2 | 2008 | 35 | 0.110 |
Why?
|
| Pregnancy | 6 | 2015 | 30237 | 0.110 |
Why?
|
| Immunoenzyme Techniques | 2 | 2014 | 1697 | 0.110 |
Why?
|
| Spine | 2 | 2002 | 1134 | 0.110 |
Why?
|
| Parents | 2 | 2018 | 3593 | 0.110 |
Why?
|
| Anorexia Nervosa | 3 | 2007 | 1328 | 0.110 |
Why?
|
| Cross-Sectional Studies | 24 | 2018 | 26310 | 0.110 |
Why?
|
| Survival Analysis | 8 | 2006 | 10100 | 0.110 |
Why?
|
| Immunoglobulin M | 3 | 2005 | 1527 | 0.110 |
Why?
|
| Child, Preschool | 16 | 2024 | 42577 | 0.110 |
Why?
|
| Immunophenotyping | 1 | 2018 | 1867 | 0.100 |
Why?
|
| Radionuclide Imaging | 5 | 1989 | 1986 | 0.100 |
Why?
|
| Pneumonia | 2 | 2002 | 2159 | 0.100 |
Why?
|
| Immunologic Factors | 2 | 2016 | 1594 | 0.100 |
Why?
|
| Dexmedetomidine | 1 | 2017 | 321 | 0.100 |
Why?
|
| Oxidative Stress | 2 | 2021 | 3139 | 0.100 |
Why?
|
| DNA Damage | 1 | 2003 | 2467 | 0.100 |
Why?
|
| Tritium | 7 | 2003 | 707 | 0.100 |
Why?
|
| Immunoglobulins | 2 | 2014 | 853 | 0.100 |
Why?
|
| Diet, Reducing | 5 | 2002 | 487 | 0.100 |
Why?
|
| Follow-Up Studies | 17 | 2017 | 39309 | 0.100 |
Why?
|
| Risk Factors | 14 | 2024 | 74881 | 0.100 |
Why?
|
| Gene Deletion | 3 | 2023 | 2669 | 0.100 |
Why?
|
| United States | 14 | 2024 | 72951 | 0.100 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2014 | 446 | 0.100 |
Why?
|
| Acute Kidney Injury | 1 | 2024 | 1946 | 0.100 |
Why?
|
| Bone Resorption | 3 | 2001 | 721 | 0.100 |
Why?
|
| Biological Assay | 1 | 2015 | 626 | 0.100 |
Why?
|
| Pulmonary Artery | 2 | 2022 | 1938 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2006 | 12245 | 0.100 |
Why?
|
| Veterans Health | 1 | 2013 | 216 | 0.100 |
Why?
|
| Osteoporosis | 4 | 2009 | 1581 | 0.100 |
Why?
|
| Eosinophils | 1 | 2016 | 952 | 0.100 |
Why?
|
| Infant | 5 | 2024 | 36461 | 0.090 |
Why?
|
| Running | 3 | 1992 | 488 | 0.090 |
Why?
|
| Cardiac Output | 6 | 1996 | 838 | 0.090 |
Why?
|
| Immunosorbent Techniques | 2 | 2002 | 174 | 0.090 |
Why?
|
| Societies, Scientific | 2 | 2014 | 221 | 0.090 |
Why?
|
| Bone Diseases, Metabolic | 3 | 2005 | 407 | 0.090 |
Why?
|
| Cell Adhesion | 1 | 2018 | 3093 | 0.090 |
Why?
|
| Waist Circumference | 2 | 2012 | 934 | 0.090 |
Why?
|
| Pericardium | 1 | 1995 | 681 | 0.090 |
Why?
|
| Molecular Biology | 1 | 1994 | 573 | 0.090 |
Why?
|
| Disease Models, Animal | 6 | 2017 | 18330 | 0.090 |
Why?
|
| Peptide Fragments | 4 | 2007 | 5143 | 0.090 |
Why?
|
| Parenting | 1 | 2017 | 708 | 0.090 |
Why?
|
| Hematologic Tests | 1 | 2012 | 239 | 0.090 |
Why?
|
| Disease Management | 1 | 2021 | 2533 | 0.090 |
Why?
|
| Corneal Transplantation | 1 | 2014 | 315 | 0.090 |
Why?
|
| Intensive Care Units | 2 | 2023 | 3799 | 0.090 |
Why?
|
| Potassium Radioisotopes | 4 | 2008 | 12 | 0.090 |
Why?
|
| Acyclovir | 2 | 2002 | 266 | 0.090 |
Why?
|
| Gene Expression Profiling | 2 | 2019 | 9525 | 0.090 |
Why?
|
| Extracorporeal Circulation | 3 | 2017 | 182 | 0.090 |
Why?
|
| Proteins | 9 | 2003 | 6002 | 0.080 |
Why?
|
| Liver Transplantation | 3 | 2014 | 2416 | 0.080 |
Why?
|
| Lung Diseases | 2 | 2016 | 1941 | 0.080 |
Why?
|
| Physical Exertion | 3 | 1988 | 667 | 0.080 |
Why?
|
| Heart Valve Prosthesis Implantation | 3 | 2006 | 1564 | 0.080 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2015 | 1331 | 0.080 |
Why?
|
| Hospitals, University | 1 | 2011 | 572 | 0.080 |
Why?
|
| Whole-Body Irradiation | 1 | 2010 | 438 | 0.080 |
Why?
|
| Ethics, Medical | 2 | 2000 | 785 | 0.080 |
Why?
|
| Menstruation | 2 | 2007 | 310 | 0.080 |
Why?
|
| Hypertriglyceridemia | 2 | 1991 | 292 | 0.080 |
Why?
|
| Blood Volume | 2 | 2006 | 544 | 0.080 |
Why?
|
| Sensitivity and Specificity | 9 | 2009 | 14652 | 0.080 |
Why?
|
| Lipid Metabolism | 3 | 1995 | 1895 | 0.080 |
Why?
|
| Models, Chemical | 1 | 1991 | 607 | 0.080 |
Why?
|
| Benzamidines | 2 | 1999 | 20 | 0.080 |
Why?
|
| Point-of-Care Systems | 1 | 2018 | 1217 | 0.080 |
Why?
|
| Rest | 2 | 2010 | 940 | 0.080 |
Why?
|
| Heel | 1 | 2009 | 38 | 0.080 |
Why?
|
| Kinetics | 3 | 2015 | 6287 | 0.080 |
Why?
|
| Aspirin | 5 | 2008 | 3135 | 0.080 |
Why?
|
| Complement C1 Inhibitor Protein | 2 | 2007 | 97 | 0.080 |
Why?
|
| Exercise | 3 | 2001 | 5945 | 0.080 |
Why?
|
| Mexican Americans | 1 | 2009 | 165 | 0.080 |
Why?
|
| Kidney Failure, Chronic | 2 | 2002 | 2505 | 0.080 |
Why?
|
| Calibration | 4 | 2008 | 814 | 0.080 |
Why?
|
| Ganciclovir | 3 | 2002 | 256 | 0.080 |
Why?
|
| Extracellular Fluid | 2 | 2007 | 165 | 0.080 |
Why?
|
| Zoonoses | 1 | 2009 | 180 | 0.080 |
Why?
|
| Trace Elements | 1 | 1990 | 193 | 0.080 |
Why?
|
| Quality of Life | 5 | 2023 | 13476 | 0.080 |
Why?
|
| Atrial Fibrillation | 2 | 2023 | 5182 | 0.070 |
Why?
|
| Transfection | 1 | 1996 | 5754 | 0.070 |
Why?
|
| Liver | 3 | 2022 | 7571 | 0.070 |
Why?
|
| Fibrinolytic Agents | 3 | 2008 | 2078 | 0.070 |
Why?
|
| Mitochondria | 1 | 2021 | 3677 | 0.070 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 1 | 2009 | 306 | 0.070 |
Why?
|
| Perioperative Care | 2 | 2023 | 1043 | 0.070 |
Why?
|
| Predictive Value of Tests | 9 | 2007 | 15416 | 0.070 |
Why?
|
| Cryopreservation | 2 | 2004 | 727 | 0.070 |
Why?
|
| Killer Cells, Natural | 1 | 2017 | 2210 | 0.070 |
Why?
|
| Radioisotopes | 4 | 1991 | 509 | 0.070 |
Why?
|
| Papio anubis | 1 | 2007 | 23 | 0.070 |
Why?
|
| Collagen Type I | 2 | 2009 | 616 | 0.070 |
Why?
|
| Titrimetry | 1 | 2007 | 36 | 0.070 |
Why?
|
| Organisms, Genetically Modified | 1 | 2007 | 63 | 0.070 |
Why?
|
| Biopsy | 6 | 2007 | 6779 | 0.070 |
Why?
|
| Heart Defects, Congenital | 1 | 2024 | 4712 | 0.070 |
Why?
|
| Drug Resistance | 3 | 2008 | 1592 | 0.070 |
Why?
|
| Calcium, Dietary | 2 | 2001 | 527 | 0.070 |
Why?
|
| Organ Size | 6 | 2004 | 2261 | 0.070 |
Why?
|
| Warm Ischemia | 1 | 2007 | 64 | 0.070 |
Why?
|
| Surgical Flaps | 1 | 1995 | 1680 | 0.070 |
Why?
|
| Cohort Studies | 12 | 2015 | 41710 | 0.070 |
Why?
|
| Hemostatics | 2 | 2008 | 247 | 0.070 |
Why?
|
| Erythrovirus | 1 | 2006 | 2 | 0.070 |
Why?
|
| Drug Therapy, Combination | 1 | 2017 | 6307 | 0.070 |
Why?
|
| Oxygen Consumption | 5 | 2004 | 1874 | 0.070 |
Why?
|
| Models, Structural | 3 | 1997 | 339 | 0.070 |
Why?
|
| S100 Proteins | 1 | 2007 | 215 | 0.070 |
Why?
|
| Bones of Lower Extremity | 1 | 2006 | 6 | 0.070 |
Why?
|
| Kidney Function Tests | 2 | 2006 | 685 | 0.070 |
Why?
|
| Parvoviridae Infections | 1 | 2006 | 39 | 0.070 |
Why?
|
| Pancreas Transplantation | 1 | 2007 | 194 | 0.070 |
Why?
|
| Peritoneal Dialysis | 2 | 1998 | 161 | 0.070 |
Why?
|
| Coronary Artery Bypass | 3 | 2006 | 2188 | 0.060 |
Why?
|
| Puerto Rico | 2 | 1998 | 380 | 0.060 |
Why?
|
| Methods | 6 | 1992 | 1065 | 0.060 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2017 | 1481 | 0.060 |
Why?
|
| Obesity, Morbid | 4 | 2006 | 1292 | 0.060 |
Why?
|
| International Cooperation | 2 | 2009 | 1434 | 0.060 |
Why?
|
| Infant, Newborn | 3 | 2024 | 26389 | 0.060 |
Why?
|
| Lymphocyte Culture Test, Mixed | 3 | 2008 | 511 | 0.060 |
Why?
|
| Lithium | 3 | 1982 | 599 | 0.060 |
Why?
|
| Valine | 1 | 2007 | 410 | 0.060 |
Why?
|
| Receptors, Complement | 2 | 2003 | 254 | 0.060 |
Why?
|
| Dietary Carbohydrates | 1 | 1990 | 896 | 0.060 |
Why?
|
| Thrombophilia | 2 | 2005 | 308 | 0.060 |
Why?
|
| Receptors, Cell Surface | 1 | 2014 | 2815 | 0.060 |
Why?
|
| Complement C4b | 1 | 2005 | 125 | 0.060 |
Why?
|
| Retroviridae | 1 | 2008 | 846 | 0.060 |
Why?
|
| Sex Distribution | 6 | 2012 | 2274 | 0.060 |
Why?
|
| Dietary Proteins | 1 | 1990 | 960 | 0.060 |
Why?
|
| Femoral Fractures | 1 | 2009 | 376 | 0.060 |
Why?
|
| Twins, Monozygotic | 3 | 2006 | 471 | 0.060 |
Why?
|
| Prospective Studies | 16 | 2015 | 54871 | 0.060 |
Why?
|
| Risk | 3 | 2009 | 9602 | 0.060 |
Why?
|
| Heparin | 3 | 2007 | 1636 | 0.060 |
Why?
|
| Leukopenia | 1 | 2005 | 213 | 0.060 |
Why?
|
| Deuterium Oxide | 2 | 2003 | 34 | 0.060 |
Why?
|
| Estradiol | 3 | 2007 | 1947 | 0.060 |
Why?
|
| Consensus | 1 | 2014 | 3208 | 0.060 |
Why?
|
| Pulmonary Gas Exchange | 1 | 2006 | 389 | 0.060 |
Why?
|
| Longitudinal Studies | 8 | 2010 | 14762 | 0.060 |
Why?
|
| Postoperative Period | 2 | 2006 | 1824 | 0.060 |
Why?
|
| Abdominal Fat | 1 | 2006 | 217 | 0.060 |
Why?
|
| Extremities | 3 | 2002 | 869 | 0.060 |
Why?
|
| Bronchiolitis Obliterans | 1 | 2006 | 221 | 0.060 |
Why?
|
| Medical Illustration | 1 | 2005 | 134 | 0.060 |
Why?
|
| Nerve Growth Factors | 1 | 2007 | 564 | 0.060 |
Why?
|
| Cells | 2 | 2003 | 162 | 0.060 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2009 | 398 | 0.060 |
Why?
|
| Malnutrition | 1 | 2010 | 629 | 0.050 |
Why?
|
| Graft vs Host Reaction | 1 | 2003 | 99 | 0.050 |
Why?
|
| Complement C5a | 1 | 2003 | 100 | 0.050 |
Why?
|
| Body Weights and Measures | 2 | 2003 | 208 | 0.050 |
Why?
|
| Algorithms | 6 | 2012 | 14072 | 0.050 |
Why?
|
| Growth | 3 | 2000 | 365 | 0.050 |
Why?
|
| Electrolytes | 2 | 2001 | 279 | 0.050 |
Why?
|
| Blood Physiological Phenomena | 1 | 2003 | 53 | 0.050 |
Why?
|
| Fluoxetine | 1 | 2007 | 732 | 0.050 |
Why?
|
| Thromboxane B2 | 1 | 2003 | 143 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2023 | 1805 | 0.050 |
Why?
|
| Organ Preservation Solutions | 2 | 2019 | 105 | 0.050 |
Why?
|
| HIV Seropositivity | 1 | 1989 | 962 | 0.050 |
Why?
|
| Body Fluids | 5 | 1994 | 321 | 0.050 |
Why?
|
| Arm | 2 | 2006 | 591 | 0.050 |
Why?
|
| Scedosporium | 1 | 2002 | 10 | 0.050 |
Why?
|
| Energy Intake | 6 | 2002 | 2142 | 0.050 |
Why?
|
| Palatine Tonsil | 1 | 2003 | 193 | 0.050 |
Why?
|
| Sodium | 6 | 1992 | 1594 | 0.050 |
Why?
|
| Mycetoma | 1 | 2002 | 18 | 0.050 |
Why?
|
| Erythrocytes | 2 | 2022 | 2412 | 0.050 |
Why?
|
| RNA, Messenger | 4 | 2019 | 12791 | 0.050 |
Why?
|
| Mammography | 1 | 2013 | 2429 | 0.050 |
Why?
|
| Intracellular Space | 1 | 2003 | 198 | 0.050 |
Why?
|
| Autoantigens | 1 | 2007 | 886 | 0.050 |
Why?
|
| Viscera | 1 | 2003 | 138 | 0.050 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2024 | 325 | 0.050 |
Why?
|
| Abdomen | 3 | 2003 | 1137 | 0.050 |
Why?
|
| Renal Replacement Therapy | 1 | 2024 | 282 | 0.050 |
Why?
|
| Spleen | 2 | 2003 | 2295 | 0.050 |
Why?
|
| Bronchial Diseases | 1 | 2003 | 151 | 0.050 |
Why?
|
| Clodronic Acid | 1 | 2022 | 60 | 0.050 |
Why?
|
| Postoperative Hemorrhage | 1 | 2006 | 418 | 0.050 |
Why?
|
| Head | 1 | 2008 | 926 | 0.050 |
Why?
|
| Chemokines | 2 | 2018 | 962 | 0.050 |
Why?
|
| Trisaccharides | 1 | 2001 | 50 | 0.050 |
Why?
|
| Nucleic Acid Amplification Techniques | 2 | 2019 | 335 | 0.050 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2003 | 215 | 0.050 |
Why?
|
| Cardiopulmonary Bypass | 5 | 2007 | 1097 | 0.050 |
Why?
|
| Cells, Cultured | 4 | 2015 | 18984 | 0.050 |
Why?
|
| Sternum | 1 | 2002 | 177 | 0.050 |
Why?
|
| Bone Marrow Transplantation | 2 | 2006 | 2730 | 0.050 |
Why?
|
| Hematocrit | 1 | 2003 | 622 | 0.050 |
Why?
|
| Pregnancy Complications | 1 | 2015 | 2971 | 0.050 |
Why?
|
| Thinness | 1 | 2005 | 482 | 0.050 |
Why?
|
| Resource Allocation | 1 | 2004 | 354 | 0.050 |
Why?
|
| Young Adult | 7 | 2017 | 59939 | 0.050 |
Why?
|
| Flow Cytometry | 3 | 2011 | 5890 | 0.050 |
Why?
|
| Antigen Presentation | 1 | 2007 | 1250 | 0.050 |
Why?
|
| Regional Blood Flow | 2 | 2012 | 1478 | 0.050 |
Why?
|
| Lymphocytes | 3 | 2010 | 2605 | 0.050 |
Why?
|
| Risk Assessment | 4 | 2017 | 24295 | 0.050 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2005 | 361 | 0.050 |
Why?
|
| Histoplasmosis | 1 | 2001 | 63 | 0.050 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 2 | 2001 | 975 | 0.050 |
Why?
|
| Cytoplasm | 1 | 2005 | 1505 | 0.050 |
Why?
|
| Muscular Atrophy | 2 | 2001 | 335 | 0.050 |
Why?
|
| Cardioplegic Solutions | 1 | 2001 | 123 | 0.050 |
Why?
|
| Bioprosthesis | 1 | 2005 | 593 | 0.050 |
Why?
|
| Prostaglandins | 1 | 2002 | 398 | 0.050 |
Why?
|
| Coronary Stenosis | 1 | 2006 | 803 | 0.040 |
Why?
|
| Premenopause | 2 | 2003 | 1039 | 0.040 |
Why?
|
| Exercise Test | 3 | 1999 | 2188 | 0.040 |
Why?
|
| Linear Models | 2 | 2004 | 5874 | 0.040 |
Why?
|
| Mediastinal Diseases | 1 | 2001 | 91 | 0.040 |
Why?
|
| Mannitol | 1 | 2001 | 176 | 0.040 |
Why?
|
| Actuarial Analysis | 1 | 2000 | 370 | 0.040 |
Why?
|
| Wound Infection | 1 | 2002 | 244 | 0.040 |
Why?
|
| Antigens, CD19 | 1 | 2003 | 444 | 0.040 |
Why?
|
| Rubidium | 1 | 1980 | 120 | 0.040 |
Why?
|
| Thromboembolism | 1 | 2007 | 1003 | 0.040 |
Why?
|
| Histidine | 1 | 2001 | 301 | 0.040 |
Why?
|
| Blotting, Western | 2 | 2005 | 5022 | 0.040 |
Why?
|
| Fatal Outcome | 2 | 2002 | 1838 | 0.040 |
Why?
|
| Cryosurgery | 1 | 2005 | 478 | 0.040 |
Why?
|
| United States Food and Drug Administration | 2 | 2009 | 1673 | 0.040 |
Why?
|
| Peptides | 3 | 2009 | 4344 | 0.040 |
Why?
|
| Immunotherapy | 1 | 2016 | 4747 | 0.040 |
Why?
|
| Myocardial Contraction | 2 | 1999 | 1516 | 0.040 |
Why?
|
| Plasma Cells | 1 | 2003 | 599 | 0.040 |
Why?
|
| Caloric Restriction | 1 | 2002 | 303 | 0.040 |
Why?
|
| Galactosides | 1 | 1999 | 54 | 0.040 |
Why?
|
| Virus Diseases | 1 | 2006 | 720 | 0.040 |
Why?
|
| Glutamates | 1 | 2001 | 384 | 0.040 |
Why?
|
| Thromboplastin | 2 | 2014 | 289 | 0.040 |
Why?
|
| Treatment Failure | 2 | 2005 | 2659 | 0.040 |
Why?
|
| Sulfates | 2 | 1996 | 380 | 0.040 |
Why?
|
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2001 | 163 | 0.040 |
Why?
|
| Multicenter Studies as Topic | 1 | 2005 | 1733 | 0.040 |
Why?
|
| Constriction, Pathologic | 1 | 2003 | 1103 | 0.040 |
Why?
|
| Antigen-Presenting Cells | 2 | 2015 | 960 | 0.040 |
Why?
|
| Hydrocortisone | 3 | 2007 | 1838 | 0.040 |
Why?
|
| Lipids | 7 | 1993 | 3319 | 0.040 |
Why?
|
| Bone Demineralization, Pathologic | 1 | 1999 | 7 | 0.040 |
Why?
|
| Cyclophosphamide | 2 | 2002 | 2234 | 0.040 |
Why?
|
| Benchmarking | 1 | 2006 | 1056 | 0.040 |
Why?
|
| Hot Temperature | 2 | 1997 | 1442 | 0.040 |
Why?
|
| Early Detection of Cancer | 1 | 2013 | 3236 | 0.040 |
Why?
|
| Adrenal Glands | 1 | 2001 | 556 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2003 | 1756 | 0.040 |
Why?
|
| Deuterium | 2 | 1996 | 105 | 0.040 |
Why?
|
| Scattering, Radiation | 2 | 1991 | 483 | 0.040 |
Why?
|
| Antibody Specificity | 1 | 2001 | 1062 | 0.040 |
Why?
|
| Vitamin D | 3 | 2009 | 3270 | 0.040 |
Why?
|
| Endocardium | 1 | 2019 | 249 | 0.040 |
Why?
|
| Glutathione | 1 | 2001 | 589 | 0.040 |
Why?
|
| Thymus Gland | 1 | 2003 | 1260 | 0.040 |
Why?
|
| Macaca mulatta | 3 | 2012 | 2341 | 0.040 |
Why?
|
| Warfarin | 1 | 2007 | 1494 | 0.040 |
Why?
|
| Genes, Essential | 1 | 2019 | 185 | 0.040 |
Why?
|
| Decision Making | 2 | 2017 | 3951 | 0.040 |
Why?
|
| Dogs | 4 | 2007 | 3834 | 0.040 |
Why?
|
| Vascular Patency | 3 | 2006 | 915 | 0.040 |
Why?
|
| Suture Techniques | 1 | 2003 | 775 | 0.040 |
Why?
|
| Respiratory Tract Infections | 1 | 2006 | 1008 | 0.040 |
Why?
|
| Monte Carlo Method | 3 | 1998 | 1250 | 0.040 |
Why?
|
| Texas | 1 | 1999 | 410 | 0.040 |
Why?
|
| Diseases in Twins | 1 | 2000 | 447 | 0.040 |
Why?
|
| Osteocalcin | 3 | 2007 | 271 | 0.040 |
Why?
|
| Influenza Vaccines | 1 | 2005 | 780 | 0.040 |
Why?
|
| Italy | 1 | 2000 | 856 | 0.040 |
Why?
|
| Equipment Design | 3 | 2018 | 3487 | 0.040 |
Why?
|
| Sucrose | 1 | 1978 | 155 | 0.040 |
Why?
|
| Complement Membrane Attack Complex | 1 | 1998 | 105 | 0.040 |
Why?
|
| Pulmonary Fibrosis | 1 | 2002 | 505 | 0.040 |
Why?
|
| Blood Pressure | 7 | 2002 | 8533 | 0.040 |
Why?
|
| Immobilization | 1 | 1999 | 227 | 0.040 |
Why?
|
| Disease Outbreaks | 1 | 2007 | 1761 | 0.040 |
Why?
|
| Antigens, Differentiation | 1 | 2001 | 921 | 0.040 |
Why?
|
| Tunica Intima | 1 | 1999 | 455 | 0.040 |
Why?
|
| Tomography | 1 | 2000 | 443 | 0.040 |
Why?
|
| Prednisone | 1 | 2002 | 1566 | 0.040 |
Why?
|
| Bronchoscopy | 1 | 2003 | 913 | 0.040 |
Why?
|
| Heart Atria | 1 | 2023 | 1361 | 0.030 |
Why?
|
| Health Care Rationing | 1 | 2000 | 435 | 0.030 |
Why?
|
| Registries | 3 | 2005 | 8351 | 0.030 |
Why?
|
| Education, Medical, Continuing | 1 | 1982 | 830 | 0.030 |
Why?
|
| Heart Arrest | 1 | 2007 | 1516 | 0.030 |
Why?
|
| Pyrazoles | 1 | 2007 | 2030 | 0.030 |
Why?
|
| Escherichia coli Infections | 1 | 2001 | 518 | 0.030 |
Why?
|
| Gastrointestinal Hemorrhage | 2 | 2001 | 1126 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2005 | 2870 | 0.030 |
Why?
|
| Heart Valve Prosthesis | 1 | 2005 | 1464 | 0.030 |
Why?
|
| RNA | 1 | 2006 | 2715 | 0.030 |
Why?
|
| Myocardial Infarction | 3 | 2006 | 11513 | 0.030 |
Why?
|
| Thromboxane-A Synthase | 1 | 1996 | 34 | 0.030 |
Why?
|
| Sulfur Radioisotopes | 1 | 1996 | 113 | 0.030 |
Why?
|
| HIV Protease Inhibitors | 1 | 1999 | 430 | 0.030 |
Why?
|
| Receptors, Thromboxane | 1 | 1996 | 30 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 1999 | 10745 | 0.030 |
Why?
|
| Thromboxane A2 | 1 | 1996 | 87 | 0.030 |
Why?
|
| Dyspnea, Paroxysmal | 1 | 1995 | 3 | 0.030 |
Why?
|
| Shock, Cardiogenic | 1 | 2002 | 709 | 0.030 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 1989 | 4410 | 0.030 |
Why?
|
| Pregnancy Trimester, Third | 1 | 1999 | 587 | 0.030 |
Why?
|
| Respiration | 4 | 2006 | 1654 | 0.030 |
Why?
|
| Brain | 2 | 2022 | 27159 | 0.030 |
Why?
|
| Stroke Volume | 3 | 1989 | 5618 | 0.030 |
Why?
|
| Bromine | 1 | 1975 | 23 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2003 | 2413 | 0.030 |
Why?
|
| Protein Kinase C | 1 | 2000 | 1206 | 0.030 |
Why?
|
| Isoenzymes | 1 | 2000 | 1688 | 0.030 |
Why?
|
| Physical Education and Training | 1 | 1996 | 102 | 0.030 |
Why?
|
| Methacrylates | 1 | 1996 | 109 | 0.030 |
Why?
|
| Body Surface Area | 4 | 2007 | 206 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2017 | 23619 | 0.030 |
Why?
|
| Basal Metabolism | 2 | 1990 | 163 | 0.030 |
Why?
|
| Self-Assessment | 1 | 1998 | 400 | 0.030 |
Why?
|
| Thrombomodulin | 1 | 2016 | 107 | 0.030 |
Why?
|
| Postmenopause | 2 | 2003 | 2517 | 0.030 |
Why?
|
| Lectins | 1 | 2017 | 490 | 0.030 |
Why?
|
| Cold Temperature | 1 | 2019 | 794 | 0.030 |
Why?
|
| Isoproterenol | 3 | 1972 | 398 | 0.030 |
Why?
|
| Vasculitis | 1 | 1999 | 528 | 0.030 |
Why?
|
| Endothelin-1 | 2 | 2007 | 297 | 0.030 |
Why?
|
| Bone Diseases | 1 | 1999 | 412 | 0.030 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2007 | 2808 | 0.030 |
Why?
|
| Gadolinium | 2 | 1991 | 964 | 0.030 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 1998 | 482 | 0.030 |
Why?
|
| Longevity | 1 | 2003 | 1083 | 0.030 |
Why?
|
| Chronic Disease | 2 | 2007 | 9357 | 0.030 |
Why?
|
| Food Services | 1 | 2018 | 209 | 0.030 |
Why?
|
| Caspase 3 | 2 | 2007 | 730 | 0.030 |
Why?
|
| Vaccines | 1 | 2003 | 842 | 0.030 |
Why?
|
| Platelet Function Tests | 2 | 2007 | 275 | 0.030 |
Why?
|
| Water | 2 | 1978 | 1417 | 0.030 |
Why?
|
| Lumbosacral Region | 1 | 1996 | 294 | 0.030 |
Why?
|
| Pregnancy Trimester, First | 1 | 1999 | 917 | 0.030 |
Why?
|
| Primary Graft Dysfunction | 1 | 2015 | 112 | 0.030 |
Why?
|
| Methacholine Compounds | 2 | 1972 | 35 | 0.030 |
Why?
|
| Viral Load | 2 | 2000 | 3385 | 0.030 |
Why?
|
| Computer Simulation | 2 | 1998 | 6259 | 0.030 |
Why?
|
| Health Status | 2 | 2001 | 4087 | 0.030 |
Why?
|
| Hypertonic Solutions | 1 | 1973 | 82 | 0.030 |
Why?
|
| Antibodies, Viral | 2 | 2006 | 3212 | 0.030 |
Why?
|
| Electric Conductivity | 2 | 1991 | 405 | 0.030 |
Why?
|
| Carbon Dioxide | 1 | 2018 | 1138 | 0.030 |
Why?
|
| Brain Ischemia | 1 | 2007 | 3001 | 0.030 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2023 | 1414 | 0.030 |
Why?
|
| Coronary Circulation | 1 | 1999 | 1602 | 0.030 |
Why?
|
| Aortic Valve Stenosis | 1 | 2006 | 2023 | 0.030 |
Why?
|
| Arteries | 3 | 2014 | 1123 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2003 | 3641 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1998 | 2470 | 0.030 |
Why?
|
| Tomography, Optical Coherence | 1 | 2006 | 2937 | 0.030 |
Why?
|
| Coronary Disease | 6 | 1996 | 5915 | 0.030 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1999 | 1494 | 0.030 |
Why?
|
| Antithrombins | 1 | 1996 | 294 | 0.030 |
Why?
|
| Vasoconstriction | 1 | 1996 | 592 | 0.030 |
Why?
|
| Calorimetry, Indirect | 1 | 1993 | 176 | 0.030 |
Why?
|
| Statistics as Topic | 4 | 2005 | 2351 | 0.030 |
Why?
|
| Fluorescence | 1 | 1975 | 751 | 0.030 |
Why?
|
| Environment | 1 | 1999 | 1120 | 0.030 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2001 | 1814 | 0.030 |
Why?
|
| Transgenes | 1 | 2016 | 1014 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 1 | 1995 | 1622 | 0.030 |
Why?
|
| Pancreatitis | 1 | 1999 | 1087 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2001 | 1889 | 0.030 |
Why?
|
| Photochemotherapy | 2 | 1989 | 828 | 0.030 |
Why?
|
| Blood Glucose | 2 | 2006 | 6422 | 0.020 |
Why?
|
| Age Distribution | 3 | 2005 | 2869 | 0.020 |
Why?
|
| Mice | 8 | 2023 | 81889 | 0.020 |
Why?
|
| Hydrogen | 1 | 1993 | 168 | 0.020 |
Why?
|
| Cystic Fibrosis | 1 | 2001 | 1285 | 0.020 |
Why?
|
| Colitis | 1 | 2001 | 1238 | 0.020 |
Why?
|
| Lymphocyte Activation | 2 | 2015 | 5503 | 0.020 |
Why?
|
| Blood Coagulation Factors | 1 | 2014 | 371 | 0.020 |
Why?
|
| Platelet Count | 1 | 1995 | 784 | 0.020 |
Why?
|
| Models, Anatomic | 1 | 1996 | 678 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2003 | 3468 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2009 | 7431 | 0.020 |
Why?
|
| Ligands | 1 | 1999 | 3275 | 0.020 |
Why?
|
| Serum Albumin, Radio-Iodinated | 2 | 1972 | 37 | 0.020 |
Why?
|
| Fast Neutrons | 1 | 1991 | 18 | 0.020 |
Why?
|
| Cough | 1 | 1995 | 599 | 0.020 |
Why?
|
| Prosthesis Design | 2 | 2011 | 2120 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2002 | 4166 | 0.020 |
Why?
|
| Databases, Factual | 2 | 2013 | 8066 | 0.020 |
Why?
|
| Sodium Chloride | 1 | 1973 | 580 | 0.020 |
Why?
|
| Hospitals, Veterans | 1 | 2013 | 395 | 0.020 |
Why?
|
| Cell Movement | 1 | 2023 | 5199 | 0.020 |
Why?
|
| Prognosis | 3 | 2007 | 29948 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 1995 | 1606 | 0.020 |
Why?
|
| Sweden | 1 | 2014 | 1382 | 0.020 |
Why?
|
| Sigmoid Neoplasms | 1 | 1970 | 55 | 0.020 |
Why?
|
| Zinc | 1 | 1975 | 675 | 0.020 |
Why?
|
| Adenosine Triphosphate | 2 | 2007 | 2001 | 0.020 |
Why?
|
| Triolein | 1 | 1990 | 9 | 0.020 |
Why?
|
| Xylose | 1 | 1990 | 28 | 0.020 |
Why?
|
| Estrone | 2 | 2001 | 234 | 0.020 |
Why?
|
| Critical Care | 1 | 2023 | 2714 | 0.020 |
Why?
|
| Home Nursing | 1 | 1990 | 92 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2006 | 20708 | 0.020 |
Why?
|
| Pyridinium Compounds | 2 | 2001 | 80 | 0.020 |
Why?
|
| Specific Gravity | 1 | 1989 | 18 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2007 | 3804 | 0.020 |
Why?
|
| Hypokalemia | 1 | 1970 | 152 | 0.020 |
Why?
|
| Immersion | 1 | 1989 | 37 | 0.020 |
Why?
|
| Europe | 2 | 2009 | 3430 | 0.020 |
Why?
|
| Parenteral Nutrition, Total | 1 | 1990 | 304 | 0.020 |
Why?
|
| Probability | 2 | 2004 | 2476 | 0.020 |
Why?
|
| Parathyroid Hormone | 3 | 2001 | 1791 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2002 | 3070 | 0.020 |
Why?
|
| Rabbits | 2 | 2000 | 4752 | 0.020 |
Why?
|
| Malabsorption Syndromes | 1 | 1990 | 135 | 0.020 |
Why?
|
| Schools | 1 | 2018 | 1495 | 0.020 |
Why?
|
| Dietary Supplements | 2 | 2001 | 3429 | 0.020 |
Why?
|
| Blood Gas Analysis | 2 | 2006 | 382 | 0.020 |
Why?
|
| Logistic Models | 3 | 2009 | 13278 | 0.020 |
Why?
|
| Calcineurin | 1 | 2010 | 235 | 0.020 |
Why?
|
| Behavior Therapy | 2 | 1992 | 886 | 0.020 |
Why?
|
| Amidines | 1 | 1988 | 28 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2007 | 11920 | 0.020 |
Why?
|
| Radiation Chimera | 1 | 1988 | 216 | 0.020 |
Why?
|
| Connective Tissue | 1 | 1991 | 425 | 0.020 |
Why?
|
| Pentamidine | 1 | 1988 | 44 | 0.020 |
Why?
|
| Sirolimus | 1 | 2016 | 1540 | 0.020 |
Why?
|
| Intestinal Absorption | 1 | 1990 | 400 | 0.020 |
Why?
|
| Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 1989 | 88 | 0.020 |
Why?
|
| Heart Function Tests | 2 | 2004 | 316 | 0.020 |
Why?
|
| Leukapheresis | 1 | 1989 | 150 | 0.020 |
Why?
|
| Mathematics | 2 | 1981 | 696 | 0.020 |
Why?
|
| Incidence | 2 | 2024 | 21525 | 0.020 |
Why?
|
| Multivariate Analysis | 2 | 2004 | 12064 | 0.020 |
Why?
|
| Vaccination | 1 | 2001 | 3434 | 0.020 |
Why?
|
| Asthma | 4 | 1972 | 6268 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 1982 | 3927 | 0.020 |
Why?
|
| Cardiac Volume | 1 | 1989 | 196 | 0.020 |
Why?
|
| Histocompatibility Antigens | 1 | 1989 | 479 | 0.020 |
Why?
|
| Students | 1 | 2018 | 1741 | 0.020 |
Why?
|
| Cardiomyopathy, Dilated | 2 | 1996 | 843 | 0.020 |
Why?
|
| Progesterone | 1 | 1992 | 752 | 0.020 |
Why?
|
| Computers | 2 | 1985 | 589 | 0.020 |
Why?
|
| Breast Neoplasms | 2 | 2013 | 21162 | 0.020 |
Why?
|
| Metabolic Diseases | 1 | 1974 | 686 | 0.020 |
Why?
|
| Abortion, Induced | 1 | 1973 | 471 | 0.020 |
Why?
|
| Aerosols | 4 | 1988 | 634 | 0.020 |
Why?
|
| Blood Circulation Time | 1 | 1966 | 10 | 0.020 |
Why?
|
| Tissue Distribution | 2 | 2003 | 2275 | 0.020 |
Why?
|
| Sex Hormone-Binding Globulin | 2 | 2001 | 557 | 0.020 |
Why?
|
| Down Syndrome | 1 | 1995 | 916 | 0.020 |
Why?
|
| Adolescent Development | 1 | 2010 | 273 | 0.020 |
Why?
|
| Malondialdehyde | 1 | 2007 | 113 | 0.020 |
Why?
|
| Homeostasis | 1 | 1998 | 3342 | 0.020 |
Why?
|
| China | 1 | 1993 | 2383 | 0.020 |
Why?
|
| Prothrombin Time | 1 | 2007 | 117 | 0.020 |
Why?
|
| Interferon Type I | 1 | 1991 | 568 | 0.020 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 1988 | 241 | 0.020 |
Why?
|
| Fatty Liver | 1 | 1993 | 810 | 0.020 |
Why?
|
| Leukocyte Transfusion | 1 | 1986 | 58 | 0.020 |
Why?
|
| Paramyxoviridae | 1 | 2006 | 9 | 0.020 |
Why?
|
| Opportunistic Infections | 1 | 1989 | 376 | 0.020 |
Why?
|
| Russia | 1 | 2007 | 383 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 3 | 1990 | 6222 | 0.020 |
Why?
|
| Pulmonary Diffusing Capacity | 1 | 2006 | 93 | 0.020 |
Why?
|
| Anti-HIV Agents | 2 | 1999 | 4562 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2019 | 3618 | 0.020 |
Why?
|
| Fetus | 1 | 1973 | 1878 | 0.020 |
Why?
|
| Pulsatile Flow | 1 | 2007 | 318 | 0.020 |
Why?
|
| Retinol-Binding Proteins | 1 | 1985 | 67 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 1999 | 7609 | 0.020 |
Why?
|
| Serum Albumin | 1 | 1989 | 675 | 0.020 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2012 | 1121 | 0.020 |
Why?
|
| Lymphocyte Count | 1 | 2008 | 794 | 0.020 |
Why?
|
| Infrared Rays | 1 | 2006 | 246 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 1996 | 3721 | 0.020 |
Why?
|
| Lung Volume Measurements | 1 | 2006 | 381 | 0.020 |
Why?
|
| Radial Artery | 1 | 2006 | 187 | 0.020 |
Why?
|
| Immunologic Memory | 1 | 2012 | 1377 | 0.020 |
Why?
|
| International Normalized Ratio | 1 | 2007 | 382 | 0.020 |
Why?
|
| Mastectomy | 1 | 2013 | 1861 | 0.020 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2007 | 731 | 0.020 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 2006 | 168 | 0.010 |
Why?
|
| Monocytes | 1 | 2014 | 2600 | 0.010 |
Why?
|
| Aerobiosis | 1 | 2004 | 100 | 0.010 |
Why?
|
| Blood Coagulation Tests | 1 | 2006 | 269 | 0.010 |
Why?
|
| Luteinizing Hormone | 1 | 2007 | 828 | 0.010 |
Why?
|
| Enteral Nutrition | 1 | 1991 | 802 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2018 | 8728 | 0.010 |
Why?
|
| Immune System | 1 | 2010 | 800 | 0.010 |
Why?
|
| Mexico | 1 | 2007 | 770 | 0.010 |
Why?
|
| Random Allocation | 1 | 1989 | 2394 | 0.010 |
Why?
|
| Cardiotonic Agents | 1 | 2007 | 541 | 0.010 |
Why?
|
| Homozygote | 1 | 2009 | 1775 | 0.010 |
Why?
|
| Sweetening Agents | 1 | 1966 | 291 | 0.010 |
Why?
|
| Absorption | 1 | 1984 | 242 | 0.010 |
Why?
|
| Diet | 1 | 2002 | 8088 | 0.010 |
Why?
|
| Intracranial Thrombosis | 1 | 2005 | 109 | 0.010 |
Why?
|
| Alcoholism | 1 | 1975 | 1980 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 4 | 1990 | 22352 | 0.010 |
Why?
|
| Electrocardiography | 2 | 1989 | 6408 | 0.010 |
Why?
|
| Ovarian Neoplasms | 1 | 1981 | 4904 | 0.010 |
Why?
|
| Lactates | 1 | 2004 | 398 | 0.010 |
Why?
|
| Double-Blind Method | 3 | 2006 | 12430 | 0.010 |
Why?
|
| CD4 Lymphocyte Count | 2 | 2000 | 2586 | 0.010 |
Why?
|
| Interleukin-1 | 2 | 2002 | 1251 | 0.010 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2006 | 373 | 0.010 |
Why?
|
| Karnofsky Performance Status | 1 | 2003 | 163 | 0.010 |
Why?
|
| Interleukin-2 | 1 | 1990 | 1895 | 0.010 |
Why?
|
| Azathioprine | 2 | 2000 | 354 | 0.010 |
Why?
|
| Aneurysm, False | 1 | 2006 | 264 | 0.010 |
Why?
|
| Thrombelastography | 1 | 2006 | 194 | 0.010 |
Why?
|
| Anisotropy | 1 | 2007 | 1285 | 0.010 |
Why?
|
| Canada | 1 | 2009 | 2126 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2007 | 2478 | 0.010 |
Why?
|
| Eicosanoids | 1 | 2005 | 284 | 0.010 |
Why?
|
| Myocardial Reperfusion | 1 | 2004 | 338 | 0.010 |
Why?
|
| Dendritic Cells | 1 | 2014 | 2747 | 0.010 |
Why?
|
| Spirometry | 3 | 1972 | 929 | 0.010 |
Why?
|
| Coronary Restenosis | 1 | 2006 | 396 | 0.010 |
Why?
|
| Eating | 1 | 1990 | 1539 | 0.010 |
Why?
|
| Ventricular Function, Left | 2 | 2007 | 3935 | 0.010 |
Why?
|
| Cardiovascular System | 1 | 1970 | 839 | 0.010 |
Why?
|
| C-Reactive Protein | 1 | 2014 | 3853 | 0.010 |
Why?
|
| Microsurgery | 1 | 2008 | 798 | 0.010 |
Why?
|
| Severity of Illness Index | 3 | 2007 | 15908 | 0.010 |
Why?
|
| Systole | 1 | 2004 | 935 | 0.010 |
Why?
|
| Diastole | 1 | 2004 | 784 | 0.010 |
Why?
|
| Serpins | 1 | 2003 | 245 | 0.010 |
Why?
|
| Blood Loss, Surgical | 1 | 2006 | 642 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2006 | 1615 | 0.010 |
Why?
|
| Licensure, Medical | 1 | 1982 | 72 | 0.010 |
Why?
|
| Peroxidase | 1 | 2004 | 610 | 0.010 |
Why?
|
| Food Deprivation | 1 | 2001 | 115 | 0.010 |
Why?
|
| Secondary Prevention | 1 | 2007 | 1469 | 0.010 |
Why?
|
| Leg | 1 | 2006 | 1087 | 0.010 |
Why?
|
| CD4-CD8 Ratio | 1 | 2000 | 114 | 0.010 |
Why?
|
| Observer Variation | 1 | 2006 | 2614 | 0.010 |
Why?
|
| Preoperative Care | 3 | 2000 | 2253 | 0.010 |
Why?
|
| Hip Fractures | 1 | 2009 | 996 | 0.010 |
Why?
|
| Serotyping | 1 | 2001 | 331 | 0.010 |
Why?
|
| Temperature | 1 | 2007 | 2233 | 0.010 |
Why?
|
| Comorbidity | 2 | 2006 | 10580 | 0.010 |
Why?
|
| Stress, Physiological | 1 | 2007 | 1406 | 0.010 |
Why?
|
| Seasons | 1 | 2006 | 1521 | 0.010 |
Why?
|
| Models, Cardiovascular | 1 | 1985 | 978 | 0.010 |
Why?
|
| Syndrome | 1 | 2006 | 3271 | 0.010 |
Why?
|
| Pacemaker, Artificial | 1 | 2005 | 828 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2002 | 596 | 0.010 |
Why?
|
| Autoimmunity | 1 | 2007 | 1358 | 0.010 |
Why?
|
| Gastroplasty | 2 | 1992 | 153 | 0.010 |
Why?
|
| Bipolar Disorder | 2 | 1982 | 5130 | 0.010 |
Why?
|
| Pituitary Hormones | 1 | 2000 | 182 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2000 | 8926 | 0.010 |
Why?
|
| Electron Probe Microanalysis | 1 | 1998 | 32 | 0.010 |
Why?
|
| APACHE | 1 | 1999 | 268 | 0.010 |
Why?
|
| Cerium | 1 | 1998 | 9 | 0.010 |
Why?
|
| Urine | 1 | 2000 | 363 | 0.010 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 2001 | 264 | 0.010 |
Why?
|
| Insulin | 4 | 1992 | 6608 | 0.010 |
Why?
|
| Horseradish Peroxidase | 1 | 1998 | 169 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2004 | 2921 | 0.010 |
Why?
|
| Radioactive Tracers | 1 | 1978 | 61 | 0.010 |
Why?
|
| Feeding Behavior | 1 | 1991 | 3208 | 0.010 |
Why?
|
| Nuclear Reactors | 1 | 1998 | 8 | 0.010 |
Why?
|
| Mice, Inbred C3H | 2 | 1990 | 915 | 0.010 |
Why?
|
| Sports Medicine | 1 | 1981 | 239 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2006 | 3796 | 0.010 |
Why?
|
| Emotions | 1 | 1970 | 2758 | 0.010 |
Why?
|
| Nitrogen Isotopes | 1 | 1998 | 80 | 0.010 |
Why?
|
| Somatomedins | 1 | 1998 | 179 | 0.010 |
Why?
|
| Length of Stay | 1 | 2011 | 6490 | 0.010 |
Why?
|
| Rats | 3 | 1981 | 23717 | 0.010 |
Why?
|
| Heart Valve Diseases | 1 | 1985 | 1029 | 0.010 |
Why?
|
| Mass Screening | 1 | 2013 | 5454 | 0.010 |
Why?
|
| Administration, Oral | 3 | 1992 | 4018 | 0.010 |
Why?
|
| Pelvis | 1 | 2002 | 737 | 0.010 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2001 | 399 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2010 | 36567 | 0.010 |
Why?
|
| Infusions, Parenteral | 2 | 1975 | 395 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1998 | 697 | 0.010 |
Why?
|
| Paralysis | 1 | 1999 | 250 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 2003 | 2108 | 0.010 |
Why?
|
| Coronary Angiography | 2 | 2006 | 4508 | 0.010 |
Why?
|
| Africa | 1 | 1999 | 726 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2007 | 2976 | 0.010 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2000 | 706 | 0.010 |
Why?
|
| Software | 1 | 1990 | 4466 | 0.010 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2010 | 3114 | 0.010 |
Why?
|
| Mesentery | 1 | 1976 | 201 | 0.010 |
Why?
|
| Staphylococcal Infections | 1 | 2005 | 1396 | 0.010 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 1996 | 277 | 0.010 |
Why?
|
| Nervous System Diseases | 1 | 2006 | 1659 | 0.010 |
Why?
|
| Spectrophotometry, Atomic | 1 | 1975 | 80 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1998 | 2551 | 0.010 |
Why?
|
| Amino Acids | 1 | 2001 | 1711 | 0.010 |
Why?
|
| Thigh | 1 | 1996 | 236 | 0.010 |
Why?
|
| Hydrogen Peroxide | 1 | 1998 | 740 | 0.010 |
Why?
|
| Case-Control Studies | 2 | 2005 | 22248 | 0.010 |
Why?
|
| Classification | 1 | 1995 | 128 | 0.010 |
Why?
|
| Ethanol | 1 | 1981 | 1326 | 0.010 |
Why?
|
| Potassium Isotopes | 1 | 1974 | 9 | 0.010 |
Why?
|
| Mitochondria, Liver | 1 | 1975 | 190 | 0.010 |
Why?
|
| Radiation Protection | 1 | 1998 | 424 | 0.010 |
Why?
|
| Fibrosis | 1 | 2001 | 2077 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2002 | 4853 | 0.010 |
Why?
|
| Mitochondria, Muscle | 1 | 1975 | 171 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2000 | 4570 | 0.010 |
Why?
|
| HIV | 1 | 2000 | 1588 | 0.010 |
Why?
|
| Cerebral Hemorrhage | 1 | 2005 | 2654 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 1975 | 1377 | 0.010 |
Why?
|
| Species Specificity | 2 | 1988 | 2413 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 1970 | 6359 | 0.010 |
Why?
|
| Plasma Volume | 1 | 1972 | 31 | 0.010 |
Why?
|
| Pedigree | 1 | 1981 | 4539 | 0.010 |
Why?
|
| Collagen | 1 | 2001 | 2635 | 0.010 |
Why?
|
| Jejunoileal Bypass | 1 | 1992 | 13 | 0.010 |
Why?
|
| Personality Tests | 1 | 1992 | 80 | 0.010 |
Why?
|
| Leukemia | 1 | 1981 | 1521 | 0.010 |
Why?
|
| RNA, Viral | 1 | 2000 | 2867 | 0.010 |
Why?
|
| Cell Line | 1 | 2006 | 15563 | 0.010 |
Why?
|
| Fetal Heart | 1 | 1973 | 281 | 0.010 |
Why?
|
| Lumbar Vertebrae | 1 | 2001 | 1878 | 0.010 |
Why?
|
| Glycogen | 1 | 1992 | 252 | 0.010 |
Why?
|
| Fetal Death | 1 | 1973 | 434 | 0.010 |
Why?
|
| Amniotic Fluid | 1 | 1973 | 381 | 0.010 |
Why?
|
| Triglycerides | 2 | 1991 | 2441 | 0.010 |
Why?
|
| Apoptosis | 1 | 2007 | 9513 | 0.010 |
Why?
|
| Carbonates | 1 | 1970 | 21 | 0.010 |
Why?
|
| Chlorides | 1 | 1973 | 666 | 0.010 |
Why?
|
| Spinal Diseases | 1 | 1995 | 561 | 0.010 |
Why?
|
| Injections | 1 | 1973 | 839 | 0.010 |
Why?
|
| Barium Sulfate | 1 | 1970 | 180 | 0.010 |
Why?
|
| Kidney Diseases | 1 | 2001 | 2101 | 0.010 |
Why?
|
| Constriction | 1 | 1970 | 168 | 0.010 |
Why?
|
| Cell Count | 2 | 1985 | 1826 | 0.010 |
Why?
|
| Chlorine | 1 | 1990 | 55 | 0.010 |
Why?
|
| Atropine | 1 | 1970 | 243 | 0.010 |
Why?
|
| Heart Rate | 3 | 1970 | 4207 | 0.010 |
Why?
|
| Water-Electrolyte Balance | 1 | 1970 | 326 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2000 | 8307 | 0.010 |
Why?
|
| Methoxsalen | 1 | 1989 | 21 | 0.010 |
Why?
|
| Depressive Disorder | 1 | 1982 | 3715 | 0.010 |
Why?
|
| Hemorrhage | 1 | 1961 | 3464 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2003 | 5091 | 0.000 |
Why?
|
| Cyclosporins | 1 | 1989 | 216 | 0.000 |
Why?
|
| Colonic Neoplasms | 1 | 1981 | 2534 | 0.000 |
Why?
|
| Dipeptidyl Peptidase 4 | 1 | 1989 | 93 | 0.000 |
Why?
|
| Methoxamine | 1 | 1968 | 45 | 0.000 |
Why?
|
| Immunologic Techniques | 1 | 1989 | 212 | 0.000 |
Why?
|
| Phosphorus | 1 | 1990 | 336 | 0.000 |
Why?
|
| Escherichia coli | 1 | 2001 | 4211 | 0.000 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 1981 | 2184 | 0.000 |
Why?
|
| Receptors, Drug | 1 | 1968 | 156 | 0.000 |
Why?
|
| Thymectomy | 1 | 1988 | 200 | 0.000 |
Why?
|
| Nebulizers and Vaporizers | 1 | 1988 | 138 | 0.000 |
Why?
|
| Embryo, Mammalian | 1 | 1973 | 1675 | 0.000 |
Why?
|
| Major Histocompatibility Complex | 1 | 1990 | 880 | 0.000 |
Why?
|
| Depression | 2 | 1992 | 8228 | 0.000 |
Why?
|
| Models, Theoretical | 1 | 1998 | 3561 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 2001 | 12985 | 0.000 |
Why?
|
| Somatotypes | 1 | 1985 | 39 | 0.000 |
Why?
|
| Administration, Inhalation | 1 | 1988 | 1154 | 0.000 |
Why?
|
| Membrane Proteins | 1 | 2002 | 7868 | 0.000 |
Why?
|
| Epinephrine | 1 | 1968 | 782 | 0.000 |
Why?
|
| Radiometry | 1 | 1970 | 812 | 0.000 |
Why?
|
| Extracellular Matrix | 1 | 1992 | 1730 | 0.000 |
Why?
|
| Immunization | 1 | 1989 | 1218 | 0.000 |
Why?
|
| Gestational Age | 1 | 1973 | 3617 | 0.000 |
Why?
|
| Particle Size | 1 | 1988 | 1634 | 0.000 |
Why?
|
| Kidney Neoplasms | 1 | 1981 | 4282 | 0.000 |
Why?
|
| Adaptation, Physiological | 1 | 1991 | 1313 | 0.000 |
Why?
|
| Lipoproteins, LDL | 1 | 1987 | 642 | 0.000 |
Why?
|
| Steroids | 1 | 1989 | 936 | 0.000 |
Why?
|
| Stroke | 1 | 2006 | 9741 | 0.000 |
Why?
|
| Enzyme Activation | 1 | 1989 | 3587 | 0.000 |
Why?
|
| Skin | 1 | 1976 | 4499 | 0.000 |
Why?
|
| Motivation | 1 | 1992 | 2020 | 0.000 |
Why?
|
| Lipoproteins, HDL | 1 | 1987 | 677 | 0.000 |
Why?
|
| Patient Compliance | 1 | 1992 | 2694 | 0.000 |
Why?
|
| Cholesterol | 1 | 1991 | 2903 | 0.000 |
Why?
|
| Lithium Carbonate | 1 | 1982 | 179 | 0.000 |
Why?
|
| Ultraviolet Rays | 1 | 1986 | 1101 | 0.000 |
Why?
|
| Glucose | 1 | 1992 | 4340 | 0.000 |
Why?
|
| Thyroid Hormones | 1 | 1983 | 408 | 0.000 |
Why?
|
| Radiography | 1 | 1970 | 6968 | 0.000 |
Why?
|
| Feasibility Studies | 1 | 1991 | 5306 | 0.000 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 1991 | 4349 | 0.000 |
Why?
|
| Fasting | 1 | 1986 | 1609 | 0.000 |
Why?
|
| Anxiety | 1 | 1992 | 4670 | 0.000 |
Why?
|
| Combined Modality Therapy | 1 | 1988 | 8540 | 0.000 |
Why?
|
| Angina Pectoris | 1 | 1979 | 956 | 0.000 |
Why?
|
| Spectrophotometry, Infrared | 1 | 1973 | 116 | 0.000 |
Why?
|
| Charcoal | 1 | 1973 | 67 | 0.000 |
Why?
|
| Oxides | 1 | 1973 | 402 | 0.000 |
Why?
|
| Sympatholytics | 1 | 1968 | 82 | 0.000 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 1968 | 393 | 0.000 |
Why?
|
| Sympathetic Nervous System | 1 | 1968 | 520 | 0.000 |
Why?
|